Elevated Depressive Symptoms Shape Gut Barrier Integrity, LPS Translocation, and PUFA Composition in IBS-D: Evidence from a Low-FODMAP Dietary Intervention.

IBS-D patients with elevated depressive symptoms (d+) exhibited higher small intestinal permeability at baseline compared to those without elevated depressive symptoms (d-).

• Patients were classified using the Symptom Checklist-90-Revised (SCL-90-R) depression subscale into d+ (n=23) and d- (n=20) groups.
• Small intestinal permeability (s-IP) was measured as a marker of gut barrier integrity.
• Higher baseline s-IP was observed in the d+ group, consistent with the hypothesis that mood-related factors associate with gut barrier dysfunction in IBS-D.
• The study was a single-arm pre-post design with 43 total IBS-D patients undergoing a 12-week personalized low-FODMAP diet (LFD).

Circulating lipopolysaccharide (LPS) levels were higher at baseline in IBS-D patients with elevated depressive symptoms compared to those without.

• LPS translocation was assessed as a marker of endotoxin exposure and microbial translocation across the gut barrier.
• The d+ group showed higher circulating LPS at baseline compared to the d- group.
• This finding suggests greater bacterial product translocation in IBS-D patients with comorbid depressive symptomatology.
• LPS translocation is a mechanism linking gut barrier dysfunction to systemic immune activation.

IBS-D patients with elevated depressive symptoms displayed a more pro-inflammatory erythrocyte membrane polyunsaturated fatty acid (PUFA) profile at baseline.

• Erythrocyte membrane PUFA composition was used as a marker of systemic inflammatory lipid status.
• The d+ group exhibited a more pro-inflammatory PUFA composition compared to d- patients at baseline.
• PUFA composition reflects longer-term dietary and metabolic influences on inflammatory potential.
• This finding adds a lipid-metabolic dimension to the biological burden associated with depressive symptoms in IBS-D.

Inflammatory markers were elevated at baseline in IBS-D patients with elevated depressive symptoms compared to those without.

• Multiple inflammatory markers were measured as part of the biological characterization of d+ versus d- subgroups.
• The d+ group showed higher baseline inflammatory markers, consistent with greater immune activation.
• These differences in inflammatory markers were present at baseline before any dietary intervention.
• The pattern of findings across IP, LPS, PUFAs, and inflammation collectively characterizes d+ patients as having a 'greater baseline biological burden.'

Following the 12-week low-FODMAP diet, significant improvements in symptoms and several biological parameters were observed in the overall IBS-D cohort.

• The LFD intervention lasted 12 weeks and was personalized for each participant.
• Improvements were observed across the full cohort of 43 IBS-D patients.
• Both symptomatic and biological parameters showed improvement post-intervention.
• Concurrent reduction in body weight was noted and may have influenced the observed biological changes.

Baseline depressive symptom severity was not significantly associated with the magnitude of post-intervention changes in intestinal permeability or inflammatory markers.

• Greater absolute changes in d+ patients after LFD were consistent with their higher baseline values rather than indicating differential responsiveness to the diet.
• Statistical analysis did not reveal a significant association between baseline depressive symptom level and degree of biological improvement following LFD.
• This finding suggests that d+ patients do not respond differently to LFD per se, but simply start from a higher biological burden.
• The authors caution that findings should be interpreted as associative given the single-arm design and absence of a control group.

The study identified methodological limitations including single-arm design, absence of a control group, and concurrent weight loss as potential confounders of the observed biological changes.

• No randomized control group was included, limiting causal inference.
• Concurrent reduction in body weight during the LFD intervention may have independently influenced intestinal permeability, LPS levels, inflammation, and PUFA composition.
• All findings are described as 'associative' rather than causal by the authors.
• The authors call for randomized controlled studies to clarify the role of dietary interventions in modulating gut-brain axis-related pathways in IBS-D.